In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 Months
JAMA Network Open · 16.10.2024 · 7 (10) · e2439792
DOI: 10.1001/jamanetworkopen.2024.39792 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 16.10.2024. Verfasst von Eleni G Jaswa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San…. Hauptthemen laut MEDLINE: COVID-19, Prenatal Exposure Delayed Effects, Pregnancy Complications, Infectious, SARS-CoV-2. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Importance In utero exposure to maternal infections has been associated with abnormal neurodevelopment among offspring. The emergence of a new, now endemic infection (SARS-CoV-2) warrants investigating developmental implications for exposed offspring.
Objective
To assess whether in utero exposure to maternal COVID-19 is associated with abnormal neurodevelopmental scores among children ages 12, 18, and 24 months. Design, Setting, and Participants Data were ascertained from the ASPIRE (Assessing the Safety of Pregnancy in the Coronavirus Pandemic) trial, a prospective cohort of pregnant individuals aged 18 years or older who were enrolled before 10 weeks’ gestation and their children. Individuals were recruited online from May 14, 2020, to August 23, 2021, using the Society for Assisted Reproductive Technology and BabyCenter, an online media platform. Participants from all 50 states and Puerto Rico completed activities remotely. Exposure In utero exposure to COVID-19. Main Outcomes and Measures Birth mothers completed the Ages & Stages Questionnaires, Third Edition, a validated screening tool for developmental delays, at 12, 18, and 24 months’ post partum. A score below the cutoff in any domain (communication, gross motor, fine motor, problem-solving, and social skills) was considered an abnormal developmental screen (scores range from 0 to 60 in each domain, with higher scores indicating less risk for neurodevelopmental delay).
Results
The cohort included 2003 pregnant individuals (mean [SD] age, 33.3 [4.2] years) enrolled before 10 weeks’ gestation and who completed study activities; 1750 (87.4%) had earned a college degree. Neurodevelopmental outcomes were available for 1757 children at age 12 months, 1522 at age 18 months, and 1523 at age 24 months. The prevalence of abnormal screens for exposed vs unexposed offspring at age 12 months was 64 of 198 (32.3%) vs 458 of 1559 (29.4%); at age 18 months, 36 of 161 (22.4%) vs 279 of 1361 (20.5%); and at age 24 months, 29 of 151 (19.2%) vs 230 of 1372 (16.8%). In an adjusted mixed-effects logistics regression model, no difference in risk of abnormal neurodevelopmental screens was observed at age 12 months (adjusted risk ratio [ARR], 1.07 [95% CI, 0.85-1.34]), age 18 months (ARR, 1.15 [95% CI, 0.84-1.57]), or age 24 months (ARR, 1.01 [95% CI, 0.69-1.48]). Supplemental analyses did not identify differential risk based on trimester of infection, presence vs absence of fever, or breakthrough infection following vaccination vs primary infection. Conclusions and Relevance In this cohort study of pregnant individuals and offspring, exposure to maternal COVID-19 was not associated with abnormal neurodevelopmental screening results through 24 months’ post partum. Continued study of diverse groups of children is needed because, among other factors, evidence suggests sensitivity of the developing fetal brain to maternal immune activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.
- Department of Epidemiology and Biostatistics, University of California, San Francisco.
- Division of Clinical Chemistry, Department of Laboratory Medicine, University of California, San Francisco.
- Department of Psychiatry, University of California, San Francisco.
- Division of Pediatric Infectious Disease and Global Health, Department of Pediatrics, University of California, San Francisco.
- Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.
Förderung
- NICHD NIH HHS
Zitieren
APA
Jaswa, E. G., Huddleston, H. G., Lindquist, K. J., Wu, A. H. B., Bishop, S. L., Kim, Y. S., Kaing, A., Prahl, M., Gaw, S. L., Corley, J., Hoskin, E., Cho, Y. J., Rogers, E. E., & Cedars, M. I. (2024). In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 Months. JAMA Network Open, 7(10), e2439792. https://doi.org/10.1001/jamanetworkopen.2024.39792
Vancouver
Jaswa EG, Huddleston HG, Lindquist KJ, Wu AHB, Bishop SL, Kim YS, et al. In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 Months. JAMA Network Open. 2024;7(10):e2439792. doi:10.1001/jamanetworkopen.2024.39792
BibTeX
@article{Jaswa2024,
author = {Jaswa, Eleni G and Huddleston, Heather G and Lindquist, Karla J and Wu, Alan H B and Bishop, Somer L and Kim, Young-Shin and Kaing, Amy and Prahl, Mary and Gaw, Stephanie L and Corley, Jamie and Hoskin, Elena and Cho, Yoon Jae and Rogers, Elizabeth E and Cedars, Marcelle I},
title = {In Utero Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 Months},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {10},
pages = {e2439792},
doi = {10.1001/jamanetworkopen.2024.39792}
}
EUVIMED